tiprankstipranks
Alterity Therapeutics Ltd. (PRNAF)
OTHER OTC:PRNAF
US Market

Alterity Therapeutics Ltd. (PRNAF) Financial Statements

Compare
4 Followers

Alterity Therapeutics Ltd. Financial Overview

Alterity Therapeutics Ltd.'s market cap is currently $46.37M. The company's EPS TTM is $-0.003; its P/E ratio is ―; Alterity Therapeutics Ltd. is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 4.02MAU$ 3.92MAU$ 5.12MAU$ 4.34MAU$ 0.00
Gross ProfitAU$ 3.80MAU$ 3.63MAU$ 4.76MAU$ 3.98MAU$ -112.43K
Operating IncomeAU$ -19.60MAU$ -14.64MAU$ -15.50MAU$ -15.18MAU$ -10.41M
EBITDAAU$ -19.57MAU$ -17.51MAU$ -17.39MAU$ -19.36MAU$ -13.34M
Net IncomeAU$ -19.12MAU$ -13.81MAU$ -12.85MAU$ -15.31MAU$ -9.70M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 12.64MAU$ 15.77MAU$ 34.81MAU$ 28.12MAU$ 9.20M
Total AssetsAU$ 19.22MAU$ 27.32MAU$ 41.36MAU$ 33.59MAU$ 13.30M
Total DebtAU$ 159.04KAU$ 210.38KAU$ 117.49KAU$ 65.65KAU$ 33.75K
Net DebtAU$ -12.48MAU$ -15.56MAU$ -34.69MAU$ -28.05MAU$ -9.16M
Total LiabilitiesAU$ 5.43MAU$ 4.50MAU$ 5.89MAU$ 3.12MAU$ 2.76M
Stockholders' EquityAU$ 13.80MAU$ 22.81MAU$ 35.47MAU$ 30.47MAU$ 10.55M
Cash Flow
Free Cash FlowAU$ -12.61MAU$ -20.04MAU$ -12.43MAU$ -17.34MAU$ -9.45M
Operating Cash FlowAU$ -12.61MAU$ -20.04MAU$ -12.34MAU$ -17.33MAU$ -9.43M
Investing Cash FlowAU$ -5.72KAU$ -36.46KAU$ -89.15KAU$ -10.47KAU$ -16.74K
Financing Cash FlowAU$ 9.22MAU$ 124.34KAU$ 16.30MAU$ 36.69MAU$ 3.98M
Currency in AUD

Alterity Therapeutics Ltd. Earnings and Revenue History

Alterity Therapeutics Ltd. Debt to Assets

Alterity Therapeutics Ltd. Cash Flow

Alterity Therapeutics Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis